Brazil interim results are going to be quick. With S many sites as they have enrolling right out of the gate unlike the US when it was a handful to start than slowly added sites and lots of competition Brazil has 4x as many sites enrolling with a well organized Albert Einstein network and also has a bonus set up for quick enrollment. If interim results warrant an EUA and approval HIV falls on back burner because all vials will go to covid, Most already claimed in the event of pvalue results. So what good is HIV BLA if no product to sell? If for example it got delayed 3-6 months it would no effect on revenue or sp. i believe they could than sell under open label as well.